Mechanisms for the anti-inflammatory effects of adiponectin in macrophages

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue SUPPL. 1, 2008, Pages

  Huang, Honglian ^a   Park, Pil Hoon ^a   McMullen, Megan R ^a   Nagy, Laura E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adiponectin; Alcoholic liver disease; cAMP; Inflammation; Interleukin 10

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALCOHOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; CELL ACTIVATION; CONFERENCE PAPER; CYCLIC AMP RESPONSIVE ELEMENT; CYTOKINE PRODUCTION; DESENSITIZATION; DISEASE COURSE; GENE EXPRESSION; IMMUNE RESPONSE; KUPFFER CELL; LIVER PROTECTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 40749111945     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05284.x     Document Type: Conference Paper

References (41)

1. Rehm J, Room R, Monteiro M et al. Alcohol as a risk factor for global burden of disease. Eur. Addict. Res. 2003 9 : 157 64.
2. Mills SJ, Harrison SA. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr. Gastroenterol. Rep. 2005 7 : 32 6.
3. Maddrey WC. Alcohol-induced liver disease. Clin. Liver Dis. 2000 4 : 115 31, vii.
4. Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994 106 : 1085 105.
5. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 2000 275 : 2247 50.
6. Martinez-Hernandez A, Amenta PS. The hepatic extracellular matrix II. Ontogenesis, regeneration and cirrhosis. Virchows Arch. A Pathol. Anat. 1993 423 : 77 84.
7. Gressner AM, Bachem. MG. Molecular mechanisms of liver fibrogenesis-a homage to the role of activated fat-storing cells. Digestion 1995 56 : 335 46.
8. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J. 1994 8 : 823 31.
9. Minagawa M, Deng Q, Liu ZX, Tsukamoto H, Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 2004 126 : 1387 99.
10. Nagy LE. New insights into the role of the innate immune response in the development of alcoholic liver disease. Exp. Biol. Med. 2003 228 : 882 90.
11. Markiewski MM, Mastellos D, Tudoran R et al. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J. Immunol. 2004 173 : 747 54.
12. Strey CW, Markiewski M, Mastellos D et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 2003 198 : 913 23.
13. Tuma DJ, Casey CA. Dangerous byproducts of alcohol breakdown - focus on adducts. Alcohol Res. Health 2003 27 : 285 90.
14. Kang L, Chen X, Sebastian BM et al. Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J. Biol. Chem. 2007 282 : 28 65 73.
15. Bykov I, Junnikkala S, Pekna M, Lindros KO, Meri S. Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann. Med. 2006 38 : 280 6.
16. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994 20 : 453 60.
17. Fukui H, Brauner B, Bode J, Bode C. Plasma endotoxin concentrations in patients with alcoholic and nonalcoholic liver disease: reevaluation with an improved chromogenic assay. J. Hepatol. 1991 12 : 162 9.
18. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 1987 4 : 8 14.
19. Nanji AA, Khettry U, Sadrzadeh SMH, Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4 and thromboxane B2. Am. J. Pathol. 1993 142 : 367 73.
20. Thurman RG, Mechanisms of Hepatic Toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am. J. Physiol. 1998 275 : G605 11.
21. Honchel R, Ray M, Marsano L et al. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol. Clin. Exp. Res. 1992 16 : 665 9.
22. Mathurin P, Deng Q-G, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 2000 32 : 1008 17.
23. Aldred A, Nagy LE. Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNF α production in rat Kupffer cells. Am. J. Physiol. 1999 276 : G98 106.
24. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006 6 : 772 83.
25. Pravdova E, Fickova M. Alcohol intake modulates hormonal activity of adipose tissue. Endocr. Regul. 2006 40 : 91 104.
26. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 2003 112 : 91 100.
27. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005 42 : 568 77.
28. Thakur V, Pritchard MT, McMullen MR, Nagy LE. Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Am. J. Physiol. Gastrointest. Liver Physiol. 2006 290 : G998 1007.
29. Yokota T, Oritani K, Takahashi I et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000 96 : 1723 32.
30. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 2004 316 : 924 9.
31. Yamaguchi N, Argueta JG, Masuhiro Y et al. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett. 2005 579 : 6821 6.
32. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 2004 323 : 630 5.
33. Park P, McMullen MR, Huang H, Thakur V, Nagy LE. Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-a expression via ERK1/2 activation and Egr-1 expression: role of TNF-a in adiponectin-stimulated IL-10 production. J. Biol. Chem. 2007 282 : 21 95 703.
34. Sato TA, Keelan JA, Mitchell MD. Critical paracrine interactions between TNF-alpha and IL-10 regulate lipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 production. J. Immunol. 2003 170 : 158 66.
35. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991 147 : 3815 22.
36. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991 174 : 1209 20.
37. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu. Rev. Immunol. 1993 11 : 165 90.
38. Kishore R, Tebo JM, Kolosov M, Hamilton TA. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 1999 162 : 2457 61.
39. Brown CY, Lagnado CA, Vadas MA, Goodall GJ. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J. Biol. Chem. 1996 271 : 20108 12.
40. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 1991 174 : 1549 55.
41. Akdis CA, Joss A, Akdis M, Faith A, Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J. 2000 14 : 1666 8.